In the present study, we found that CG200745 downregulates fibronectin protein levels and the mRNA levels of genes encoding fibronectin, TGFβ, and α-SMA, which were elevated in DSH rats, indicating that this treatment might prevent progressive renal injury by suppressing renal fibrosis. The gene discussed is TGFB1; the disease is renal fibrosis.